| The agency has approved two new therapies for sickle cell disease, offering hope for a long-overlooked genetic illness that can cause excruciating pain and cut decades off people's lives. The historic move includes one treatment based on CRISPR, a gene-editing tool that moved lightning-fast from a scientific breakthrough to a therapy that can alleviate suffering. | 
No comments:
Post a Comment